title: Are dose-dense and triplet chemotherapy regimens optimal adjuvant therapy in the majority of women with node-positive early breast cancer?
authors.affiliation: Liverpool Hospital, Liverpool, New South Wales, Australia.
authors.forename: Eugene J
authors.initials: EJ
authors.lastname: Moylan
authors.forename: Louise C
authors.initials: LC
authors.lastname: Connell
authors.forename: Seamus
authors.initials: S
authors.lastname: O'Reilly
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D005260:Female; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use*; D006801:Humans
chemical_list: D016179:Granulocyte Colony-Stimulating Factor